Links recommended by Dr. Lucire
Concern over suicide rate of mental health patients. 31/01/2005. ABC News Online
Link
ANTIDEPRESSANTS & SUICIDE: RISK-BENEFIT CONUNDRUMS David Healy MD ..
www.healyprozac.com/GhostlyData/JPCNDHealy.pdf
Defining Genetic Influences on Pharmacologic Responses
http://medicine.iupui.edu/flockhart/
Healthy Skepticism: Countering misleading drug promotion
http://www.healthyskepticism.org
Welcome to DrugDigest: DrugDigest is a noncommercial, evidence-based, consumer
health and drug information site dedicated to empowering consumers to make
informed choices about drugs and treatment options
http://www.drugdigest.org
International Journal of Risk & Safety in Medicine 16 (2003/2004) 31–49 31
IOS Press
Suicidality, violence and mania caused by selective serotonin reuptake
inhibitors (SSRIs): A review and analysis Peter R. Breggin
www.breggin.com/31-49.pdf
http://www.sntp.net/prozac/breggin_prozac_1.htm
Dr. Ann Blake Tracy, International Coalition for Drug Awareness – Ann Blake
Tracey author of Prozac: Panacea or Pandora?.
http://www.disinfo.com
http://www.postgradmed.com/issues/2003/08_03/ditto.htm
http://www.biopsychiatry.com/
http://www.healyprozac.com
About AHRP
Mission Statement
The
Alliance for Human Research Protection (AHRP) is a national
network of lay people and professionals dedicated to advancing responsible and
ethical medical research practices, to ensure that the human rights, dignity
and welfare of human subjects are protected, and to minimize the risks
associated with such endeavors.
http://www.ahrp.org
Social Audit
This website began as an investigation of problems with antidepressant drugs –
not only their adverse effects on many users, but also what the problem
signalled about the conduct of the competent authorities, and the adequacy of
their institutions and process. As the problem unfolded, notably between 1997
and 2003, it revealed a glimpse of pharmageddon - a world of sickness created
and sustained by exploitation of the fear of disease, indifference to real
health needs, dependence on authority, and misplaced trust in the triumph of
drug benefits over harm. These are the main themes in Medicines out of Control?
http://www.socialaudit.org.uk
http://www.socialaudit.org.uk/6040000.htm#New
United States
Food and Drug Administration.
http://www.fda.gov/cder/drug/default.htm#Clinical%20Trials
FDA Public Health Advisory
March 22, 2004
Subject: WORSENING DEPRESSION AND SUICIDALITY IN PATIENTS BEING TREATED WITH
ANTIDEPRESSANT MEDICATIONS
http://www.fda.gov/cder/drug/antidepressants/AntidepressanstPHA.htm
FDA Talk Paper
T03-70
October 27, 2003
http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01283.html
FDA Issues Public Health Advisory Entitled: Reports Of Suicidality in Pediatric
Patients Being Treated with Antidepressant Medications for Major Depressive
Disorder (MDD)
http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01256.html
FDA Talk Paper FDA Issues Public Health Advisory Entitled: Reports Of
Suicidality in Pediatric Patients Being Treated with Antidepressant Medications
for Major Depressive Disorder (MDD) October 27, 2003
Media Inquiries: 301-827-6242
Use of SSRI antidepressants in children and adolescents - updated 15 October
2004
Adverse Drug Reactions Advisory Committee
(Replaces statement of 17 June 2004)
http://www.tga.gov.au/adr/adrac_ssri.htm
Meta-Analysis: Efficacy & Safety of Antidepressants for Children - Brit
Medical Journal Sat, 10 Apr 2004
http://www.ahrp.org/infomail/04/04/10.php
RANZCP “News” release News release
For immediate release 22 April 2005.
SSRI guide released by
Australia”s leading medical
colleges
A guide has been released by three of
Australias
leading medical colleges on the use of Selective Serotonin Reuptake Inhibitors
(SSRIs) to treat children and adolescents with depression.
In a joint statement released in Melbourne today, the Royal Australian and New
Zealand College of Psychiatrists, the
Royal Australasian College
of Physicians and the Royal Australian College
of General Practitioners said the document would serve as a clinical guide for
general practitioners and other prescribers.
The three colleges were asked by the Federal Governmentís Adverse Drug Reactions
Advisory Committee (ADRAC) to produce the guide.
The chair of RANZCP Committee for Psychotropic Drugs and other Physical
Treatments, Dr Bill Lyndon, said the three colleges were responding to
questions being raised about the possible relationship between antidepressants
and suicidal thinking and suicidal behaviour.
This news release was no news at all but was an ackowledgement of the FDA
advisory which had first been posted in the
united states
on October 27th , 2003, 18 months earlier..
August 2004
National Prescribing Service News 35
• Prescribing pointers: Starting, stopping and changing antidepressants
• Talking points—improving treatment compliance
• The role of psychological and behavioural therapy
• What's what
• References
• Case study for GPs (PDF)
• Case study for pharmacists (PDF)
http://www.nps.org.au/site.php?content=/html/news.php&news=/resources/NPS_News/news35
Eli Lilly and Company Clinical Trial Registry
This site contains information about clinical trials sponsored by Eli Lilly and
Company. This information is not intended to replace the advice of a health
care professional. Only a physician can determine if a specific medicine is the
correct treatment for a particular patient. If you have questions regarding any
information contained in this site, please consult a physician.
http://www.lillytrials.com
The Lilly Suicides
The story behind the claims that SSRIs such as Prozac and Zoloft can create
aggression and suicidal tendencies as side-effects.
www.namiscc.org/News/2002/Fall/TheLillySuicides.htm
- 49k
Prior research reports, using data compiled by the World Health Organization
found that that some infants among those who suffered withdrawal symptoms
after birth, had convulsions. See:
http://www.ahrp.org/infomail/05/02/05.php
Another study, presented at a large international gathering of physicians--Digestive
Disease Week 2005 (DDW), reviewed the records of hospital inpatients
admitted with acute GI bleeding between June and December 2003. The
authors found that "the use of a common type of antidepressant may
increase gastrointestinal (GI) bleeding."
The Northwestern physicians who conducted the study noted that bleeding from
SSRIs is similar to that caused by the use of non-steroidal anti-inflammatory
drugs (NSAIDs, known as pain relievers).
They emphasized the danger of prescribing multiple drugs: "This is a
potent example of the need for doctors to be particularly conscientious
about potential side effects when prescribing multiple medications for
their patients."
However, in psychiatry, indiscriminate prescribing of drug cocktails (polypharmacy)
is the current norm and practice. Psychiatrists' practices fail to
consider the horrific consequences borne by their patients--Psychiatry's first
loyalty appears to be to their industry supporters--Current prescription
algorithms in psychiatry--which we call Psychiatry for Dummies--were
formulated to increase profits for drug manufacturers. See, the
documented case of horrors experienced by a victim of polypharmacy Aliah
Gleason, a 13 year old school child.
Medicating Aliah, in Mother Jones.
http://www.motherjones.com/news/feature/2005/05/medicating_aliah.html
WELCOME TO THE
SSRI INFORMATION BOARD
http://www.network54.com/Forum/182310
RANZCP clinical practice guidelines, an embarrassment to evidence based
practitioners.
http://www.ranzcp.org/members/publications/cpg.asp
HC 42-I
[Incorporating HC 1030-i-iii]
Published on 5 April 2005
by authority of the House of Commons
London: The Stationery Office Limited
House of Commons Health Committee
The Influence of the Pharmaceutical Industry
Fourth Report of Session 2004–05
Volume I
Report, together with formal minutes
Ordered by The House of Commons
to be printed 22 March 2005
£15.50
www.publications.parliament.uk/ pa/cm200405/cmselect/cmhealth/42/42.pdf
NSW Mental Health Sentinel Events Review Committee
Tracking Tragedy
A systemic look at suicides and homicides amongst mental health inpatients
First Report of the Committee December 2003
www.health.nsw.gov.au/policy/ cmh/publications/tracktragedy2.pdf
BMJ 2003;327:288-289 (2 August),
doi:10.1136/bmj.327.7409.288-c
Letter
Antidepressant prescribing and suicide Antidepressants do not reduce
suicide rates
EDITOR—Hall et al show that the biggest increase in the use of antidepressants
in 1990-2000 has been in the 15-44 age group.1 Simultaneously the rate
of suicide for this age span has increased in Australia. For men aged 25-34 the
use of antidepressants has increased more than six times during the period and
the suicide rate has increased by almost 17%.
http://bmj.bmjjournals.com/cgi/content/full/327/7409/288-c
Khan et al found an excess of suicidal acts on antidepressants.
compared to placebo, which has been replicated in two other analyses (10,11). ...
www.healyprozac.com/GhostlyData/JPCNDHealy.pdf
Are Antidepressants as Ineffective as They Look?
Khan, A., & Brown, WA (1991) Who should receive antidepressants?
Suggestions from
placebo treatment. Psychopharmacology Bulletin, 27, 271-274. ...
www.journals.apa.org/prevention/ volume5/pre0050026c.html - 21k
This is article number 45. Total number of articles in current ...
Hall et al do not show that antidepressants reduce the rate of suicide. ...
Free Full Text] Khan A, Khan S, Kolts R,
Brown WA. Suicide
rates in clinical ...
www.drugawareness.org/Archives/ 3rdQtr_2003/record0045.html - 11k
THE PROS AND CONS OF SSRI ANTIDEPRESSANTS
Of the newer antidepressants, venlafaxine may be slightly more effective. ...
Khan A, Khan S, Kolts R,
Brown WA. Suicide rates in clinical trials of
SSRIs, ...
www.behindthemedicalheadlines.com/ articles/anti_depressants.shtml - 20k - Cached
- Similar pages
Study Reveals startling numbers of suicides on new SSRI ...
Study Reveals startling numbers of suicides on new SSRI antidepressants ...
A recent study conducted by Arif Khan, medical director of the Northwest ...
www.healingsearch.com/_ReportPages/ study_reveals_startling_numbers_.htm - 14k - Cached
- Similar pages
Antidepressant-Placebo Debate
Khan, A., Leventhal, RM, Khan, S., & Brown, WA (2002).
Severity of depression and response to antidepressants and placebo: An
analysis of the Food and Drug ...
www.srmhp.org/0201/media-watch.html - 23k -
disinformation | antidepressants and antipsychotics increase ...
antidepressants and antipsychotics increase suicide risk by up to 68
times ... Dr. Arif Khan presented his research at a recent
meeting sponsored by the ...
www.disinfo.com/archive/pages/article/id2675/pg1/ - 32k –
Journal of Clinical Psychopharmacology - Fulltext: Volume 21(2 ...Because
"established" antidepressants often (about half the time) do not ...
Brown
WA, Khan A. Which depressed patients should receive
antidepressants? ...
www.psychopharmacology.com/pt/re/jclnpsychopharm/
fulltext.00004714-200104000-00001.htm -
Journal of Clinical Psychopharmacology - Fulltext: Volume 22(1 ...
Severity of Depression and Response to Antidepressants and Placebo: An ...
Brown WA, Khan A. Which depressed patients
should receive antidepressants? ...
www.psychopharmacology.com/pt/re/jclnpsychopharm/
fulltext.00004714-200202000-00007.htm -
[ More results from www.psychopharmacology.com ]
PROTECT YOUR CHILDREN NOW:
http://www.antidepressantsfacts.com/index.html
MEDICAL REPORTS: DANGEROUS NEUROLOGICAL SIDE-EFFECTS OF PROZAC (Sarafem,
fluoxetine)
*** Prozac (fluoxetine)-induced Mental-state, Perceptual and Emotional
Changes ***
*** Prozac-induced Akathisia & Mania can lead to aggressive and/or
homicidal behaviours ***
SUICIDE RATES HAVE DOUBLED FOR CHILDREN OF 5-14 YEARS OLD OVER THE PAST 20 YEARS!
Antidepressant & Children-suicide link: Last year 15 million
prescriptions written for children & teens
*** 5-14 year old: Doubling of Suicide rates over past 20 Years - Research
by J.W. Prescott, Ph.D. ***
FORGET THE ANTIDEPRESSANT SUICIDE ISSUE
Look at the Physical Side-Effects of Antidepressants Reported by Medical
Physicians
*** Severe Body & Brain Damaging Side-Effects of Antidepressants
***
Protect Your Children Against Bush's (July 2004) Forced
U.S.
"Mental Health Screening" and Psychiatric Drugging Program for
ALL Americans
*** The Federal PPRA Act of 1998 ***
A bitter pill: Merrilee Bentley believes antidepressants drove her
to try to kill her two children. Now, a senior judge has supported her
claim.
A Bitter Pill
by Richard Guilliatt, Sydney Morning Herald Originally published: June
19, 2004
They were lauded as the miracle drugs: a new generation of antidepressants
that promised to make us "better than well". But for Merrilee Bentley
they did the opposite: her spiral into darkness ended when she tried to
kill herself and her two children.
http://www.astrocyte-design.com/bitter-pill.html
Overview of problems in
Australia.
www.lucire.com.au
The Anti-Depressant Fact Book, 2001
Greenspiration!
Is patient non-adherence with antidepressants getting you down? Author: Dr. M.
Berber, GlaxoSmithKline
Efficacy of
Antidepressants in Adults, July 16, 2005, British Medical Journal
The
Antidepressant Solution, 2005, by Dr. Joseph Glenmullen
http://www.fda.gov/cder/drug/antidepressants/AntidepressanstPHA.htm
http://www.greenspiration.org/Article/Withdrawal.html
http://www.fda.gov/bbs/topics/news/2004/NEW01116.html
http://www.fda.gov/cder/drug/advisory/SSRI200507.htm
http://www.fda.gov/ohrms/dockets/ac/04/transcripts/4006T1.htm
http://www.fda.gov/ohrms/dockets/ac/04/transcripts/2004-4065T1.htm
http://www.hc-sc.gc.ca/english/protection/warnings/2004/2004_31.htm
http://bmj.bmjjournals.com/cgi/content/full/330/7488/396
March 2005 issue of Psychiatric Services
Magazine, by Dr. J. Pierre Loebel Thinking About Depression
Also, the owner of the following websites are all associates of mine, and
good honest ethical people:
http://www.wildestcolts.org
http://www.ablechild.org
http://www.healyprozac.com
http://www.benzo.org.uk
http://www.drugawareness.org
http://www.antidepressantsfacts.com
http://www.ahrp.org
http://www.psychrights.org
http://www.alternativementalhealth.com
http://www.truehope.com
http://www.justiceseekers.com
http://www.baumhedlundlaw.com
http://www.blockcenter.com
There are many safe treatment programs to deal with troubling symptoms a child
may be experiencing without resorting to body and brain damaging psychiatric
drugs. All of those programs should be investigated first. A
physician who fails to identify the underlying causitive factors that are
leading to troubling behaviors is simply not doing his/her job.
PsychRights®
Law Project for Psychiatric Rights
Articles & News
* New Drugs, New Problems, Australian
Journal of Forensic Sciences, 37:1, in Press as of November 6, 2005.
* Rethinking schizophrenia: its original
nature, its drug-altered character, and thoughts about its treatment,
by Nathaniel S. Lehrman, M.D., presented at the
International Center for the
Study of Psychiatry and Psychology (ICSPP) October, 2005, Conference.
* Drug Secrets: What the FDA isn't telling,
Slate, September 27, 2005, by Jeanne Lenzer
* GPs to stop prescribing antidepressants
blamed for suicidal feelings in under-18s, The Guardian (UK),
September 28, 2005.
* Little Difference Found in Schizophrenia
Drugs, The New York Times, and Generic Fares Well In Big
Psychiatry Study: Newer, Costlier Drugs Have Little Advantage for
Schizophrenia;Comparative Data on Side Effects in the Wall Street
Journal September 20, 2005, discuss the just released study from
the New England Journal of Medicine, Effectiveness of Antipsychotic Drugs
in Patients with Chronic Schizophrenia, demonstrating little if any
more benefit or fewer problems with the so-called "atypical" neuroleptics, such
as Zyprexa, Risperdal, Geodon, and Seroquel that cost so much more over the
older ones, such as Thorazine, Haldol, Prolixin and Navane.
* First trimester antidepressant risk,
from Australian Dr., describes SSRIs doubling the risk of birth defects if used
during pregnancy.
* New Antipsychotic Drugs Worrying, new study
shows, Globe and Mail, Septmber 13, 2005.
* Are ADHD drugs safe? Report finds little
proof, Tacoma Tribune, September 13th, 2005, reports the most
comprehensive scientific analysis of the drugs to date has found little
evidence that they are safe, that one drug is more effective than another or
that they help school performance.
* Anatomy of an Epidemic: Psychiatric Drugs
and the Astonishing Rise of Mental Illness in
America, by Robert
Whitaker, Ethical Human Psychology and Psychiatry, Volume 7, Number I:
23-35 Spring 2005.
* My Whole Body is Sick . . . My Life is Not
Good: A Rwandan asylum seeker attends a psychiatric clinic in London,
by Derek Summerfield, Ch. 6 from: Forced Migration and Mental Health.
Rethinking the Care of Refugees and Displaced Persons (ed D. Ingleby) New York:
Springer 2005.
* Top-selling drug (Seroxat/Paxil) linked to
increased suicide risk, London Times, August 22, 2005.
* Bay Area Street Smart's August, 2005
series on psychiatric abuses.
* Homelessness and Psychiatric Abuse
* Toxic Psychiatric Drugs: Interview with
Robert Whitaker
* Electroshock Must Be Banned
* Zyprexa: A Prescription for Disease &
Death
* The Dangers of Antidepressants
* Mental Health Policy: Humane or
Reactionary?
* Officials Bicker as Mentally Ill Wither,
Los Angeles Times, August 3, 2005.
* Context and Cooperation in Strategic
Therapy: Toward a Contextual Mental Health (Draft Copy July 28, 2005)
by
George Stone, MA, MSW.
* Huge Mental Health Victory for MN Families:
MN parents & children protected from mental health coercion & universal
screening, Edwatch, July 18, 2005
* How to Quit the Cure, Newsweek,
August 8, 2005.
* Death of the Magic Bullet, Sunday (London)
Times, July 31, 2005.
* Bitter Pill, in Columbia Journalism
Review, August 2005, describes the Media's contributing role to false
and misleading information about the safety and benefits of new drugs.
* A Curious Consensus: “Brain Scans Prove
Disease?” By Grace E. Jackson, MD, July 10, 2005 (Revised Sept. 2005)
* Stefan P Kruszewski: Schizophrenia and
Epilepsy: Untenable Link from Flawed Research Design (5 July
2005) responding to Ping Qin, Huilan Xu, Thomas Munk Laursen, Mogens
Vestergaard, and Preben Bo Mortensen, Risk for schizophrenia and
schizophrenia-like psychosis among patients with epilepsy: population based
cohort study BMJ 2005; 331: 23.
* Three Part Washington Post Series by
Shankar Vedantam on Mind and Culture: Psychiatry's Missing Diagnosis
* Patients' Diversity Is Often Discounted,
June 26, 2005.
* Social Network's Healing Power Is Borne Out
in Poorer Nations, June 27, 2005.
* Racial Disparities Found in Pinpointing
Mental Illness, Tuesday, June 28, 2005.
* June 1, 2005, Freedom of Information Act
transmittal of Adverse Reactions to Olanzapine (Zyprexa). (13 MB)
* House of Commons Health Committee: The
Influence of the Pharmaceutical Industry, March 22, 2005.
* Psychiatric Polypharmacy: A Word of Caution.
Report from PAI, Inc, of California.
* What Can We Learn from Medical
Whistleblowers? Their experiences paint a troubling picture of American
medicine's ties with the pharmaceutical industry, by Jeanne Lenzer in
the Public Library of Science (PLOS), May 27, 2005, Volume 2, Issue 7.
* Why PLoS Sponsored a Roundtable of Medical
Whistleblowers
* The Ethics of Electroconvulsive Therapy
(ECT) by Loren R. Mosher MD and David Cohen, PhD, Journal of the
American Medical Association October 2003, Volume 5, Number 10
* The Influence of Big Pharma: Wide Ranging
Report Identifies Many Areas of Influence and Distortion, British
Medical Journal, April 16, 2005, BMJ 2005;330:857–8
* Opportunity cost of antidepressant
prescribing in
England: analysis of routine
data, by Sandra Hollinghurst, David Kessler, Tim J Peters, David
Gunnell, British Medical Journal (BMJ), BMJ,
doi:10.1136/bmj.38377.715799.F7 (published 18 March 2005)
* In its February 19, 2005, issue, the British
Medical Journal (BMJ) published three articles about SSRI
Antidepressants and suicide.
* Association between suicide attempts and
selective serotonin reuptake inhibitors: systematic review of randomised
controlled trials
* Suicide, Depression and Antidepressants:
Patients and Clinicians Need to Balance Benefits and Harms
* Pills, Thrills and Bellyaches (Editorial)
* Randomized Controlled Trials: Evidence
Biased Psychiatry, By David Healy, MD MRCPsych
* An Examination of Eli Lilly and Company's
Contentions that the BMJ Prozac Documents were Never Missing and Have No
Significance, by Dr. Peter Breggin, January 12, 2005.
* Dr. Grace Jackson's June 6, 2004 Public
Lecture, "What Doctors May Not Tell You About Psychiatric Drugs,"
to the UCE Centre for Community Mental Health, in
Birmingham, England.
* California Court bans electroshock at
Santa
Barbara College Hospital on
January 5, 2005 in Akkerman v. Johnson.
* PsychRights 2004 Year-End Report.
* FDA Scientists Issued Early Warnings on
Drug Approvals: Staff Survey Echoes Safety Concerns Raised by Dr. Graham in
Senate
* In Re: Robert S, November 18, 2004,
Illinois Supreme Court Opinion holding the State of Illinois violated Robert's
constitutional rights, as a pretrial detainee in a forced medication proceeding
based on his purported best interests, by not notifying his criminal defense
attorney and failing to appoint a psychiatrist as an independent expert
witness, rather than a psychologist.
* PsychRights Joins MindFreedom Shield
Program
* Advance Directives at PsychRights
* National Mental Health Screening of
children effort likely to be orchestrated by drug companies to increase
percentage of kids on psychiatric drugs.
* Form letter invoking right to prevent
screening under the Protection of Pupil Rights Amendment (PPRA).
* Send a Message to Congress Opposing Funding
for Screening
* Bush Wants to Screen All Children for
Mental Illness, by Keith Hoeller, Ph.D., September 19, 2004, editor of Review
of Existential Psychology & Psychiatry.
* On November 12, 2004, Jim Gottstein of the
Law Offices of James B. Gottstein wrote a letter to Ted Stevens, chair of
the Senate Appropriations Committee regarding funding for screening.
* Mental Health "Parity": Why Waste Money,
Endanger Civil Liberties? Special to The
Seattle Times, Thursday, February 10, 2005, By Keith
Hoeller
* Ontario Electroshock ("ECT")
Statistics 2000-2002 (third draft), compiled by Don Weitz.
* International Consensus: ADHD and Abuse in
the Prescription of Psychopharmaceutical Drugs to Minors (January 2005)
"Giu' Le Mani Dai Bambini®" National Campaign for the Defence of Children's
Right to Health.
* Drug firms lagging on openness: Despite
vow, few studies publicized,
Boston Globe, January 9, 2005.
* The Prozac Paradox: Why antidepressants may
exacerbate depression and anxiety in some kids and teens, Popular
Science, January 2005.
* The Dictionary of Disorder, by Alix
Spiegel: How one man revolutionized psychiatry, The New Yorker, January
3, 2005, posted December 27, 2004.
* FDA to Review "Missing" Drug Company
Documents, British Medical Journal, December 31, 2004, BMJ
VOLUME 330 1 JANUARY 2005 bmj.com.
* Copy of the 1988 Document publicly
released January 4, 2005. (7 MB)
* Dispute Puts a Medical Journal Under Fire,
New York TImes, January 17, 2005.
* FDA Scientists Issued Early Warnings on
Drug Approvals: Staff Survey Echoes Safety Concerns Raised by Dr. Graham in
Senate Testimony, Union of Concerned Scientists,
December, 2004.
* Dr. Joseph Glenmullen's Q&A from ABC
News on Anti-Depressants.
* At F.D.A., Strong Drug Ties and Less
Monitoring, New York Times, December 6, 2004.
* Scientific American Mind, December
2004 Issue, Treating Depression: Pills or Talk?
* Crisis deepens at the US Food and Drug
Administration, British Medical Journal, December 4, 2004, BMJ
2004;329:1308 (4 December), doi:10.1136/bmj.329.7478.1308
* Contracts Keep Drug Research Out of Reach,
New York Times, November 29, 2004.
* Public interest group accuses FDA of trying
to discredit whistleblower, British Medical Journal, November 27, 2004
* Forbes: Antidepressants Tied to Abnormal
Bleeding
* New York Times Magazing, November 21, 2004,
The Antidepressant Dilemma.
* Stun gun deaths raise drug-link questions,
Sacramento Bee, November 13, 2004
* Bush's plan to screen for mental health
meets opposition in Illinois, British Medical Journal, November
6, 2004.
* Biomedical Bias of the American Psychiatric
Association, by Duncan B. Double, MA, MRCPsych. This is an
academic article that deconstructs the American Psychiatric Association's
September, 2003 "Statement" responding to the Fast for Freedom in Mental
Health.
* 2004 letter responding to assertions that
(1) ADHD is generally considered to be a neurochemical disorder, (2) ADHD is
present from birth, and (3)
ADHD is not caused by poor parenting, dysfunctional families, poor schooling or
nutrition.
* Did major media outlets fail to ask the
right questions about depression study? British Medical Journal,
September 25, 2004.
* Seroxat (Paxil) and Prozac 'can make people
homicidal,' The Guardian, September 21, 2004.
* Bush Wants to Screen All Children for
Mental Illness, by Keith Hoeller, Ph.D., September 19, 2004, editor of Review
of Existential Psychology & Psychiatry.
* Presentation before the FDA on September
13, 2004,
Lawrence Diller, M.D.
* FDA Urged Withholding Data on
Antidepressants Makers Were Dissuaded From Labeling Drugs as Ineffective in
Children, Washington Post, Friday, September 10, 2004.
* A Commentary on the Proposal to Observe the
Effects Of a Single Dose of Amphetamine in Children, by Jonathan Leo,
Ph.D., Submitted for the Food and Drug Administration’s Meeting of the
Pediatrics Ethics Subcommittee of the Pediatric Advisory Committee on September
10, 2004.
* Journals Insist Drug Manufacturers Register
All Trials, in the Washington Post, September 8, 2004
* GlaxoSmithKline Settles NY Fraud Suit,
promising to disclose all drug trial results, August 26, 2004. See, Consent
Decree (Settlement) and Press Release.
* Prozac Nation: Is the Party Over? By
Richard C. Morais, Forbes, August 20, 2004.
* Bush plans to screen whole
US
population for mental illness, Jeanne Lenzer New York British Medical
Journal, Vol. 328, 19 June 2004, page 1458, bmj.com (PDF Version).
* Secret US report surfaces on
antidepressants in children, by Jeanne Lenzer New York, British Medical
Journal, Vol.329 7 AUGUST 2004, page 307 bmj.com.
* Janssen, July 21, 2004 "Dear Health Care
Provider" Letter for Risperidone (Risperdal).
* April 19, 2004, FDA Warning Letter to
Janssen about its previous Dear Health Care Provider being "false or
misleading," which resulted in the July 21, 2004 letter.
* Clinical Trials Controversy Spotlights
Flawed System, by Jim Rosack, Psychiatric News July 16, 2004,
Volume 39 Number 14.
* July 2, 2004, Pennsylvania whistleblower
lawsuit by Harvard trained psychiatrist Stefan P. Kruszewski, in Pennsylvania
over Drug company/Pennsylvania State corruption involving drugging abuses,
including deaths of children.
* FDA Revisits Issue Of Antidepressants for
Youths: New Analysis May Pressure Agency to Set Limit on Use Because of Suicide
Risk, by Anna Wilde Mathews, Wall Street Journal, August 5, 2004; Page
A1.
* The Biology of Mental Illness, by
Jonathon Leo in Society, July/August 2004. Dr. Leo goes through
the lack of any evidence supporting the current conventional wisdom that mental
illness is an actual disease.
* FDA’s counsel accused of being too close to
drug industry, Jeanne Lenzer New York, BMJ VOLUME 329 24 JULY 2004.
* Mum free after murder bid.
* Eli Lilly, Zyprexa and the Bush Family,
by Bruce Levine in Z Magazine Online, May 2004 Volume 17 Number 5
* The evidence base: rock of certainty or
shifting sands? by John Dewhurst, retired pharmaceutical physician,
British Medical Journal, April 17, 2004, BMJ 2004;328:963 (17 April),
doi:10.1136/bmj.328.7445.963
* All the Things They Taught Us That Were
Wrong, by Thomas A. M. Kramer, MD Psychopharmacology Today, 2004;6(2):e19.
* Interview of Dr. Loren Mosher in the April
2004 issue of Mental Health Today (UK).
* LA Times, April 6, 2004: FDA Sat on Report
Linking Suicide, Drugs
* New York Times' February 25, 2004 article
on Eli Lilly and Zyprexa, which includes that "In the last year, doctors have
learned that its side effects include diabetes, stroke and death."
* Allen Jones' Full Whistle-Blower Report on
Drug Company influence on states' drug purchases.
* NY Times 2/1/2004, article, Making
Drugs, Shaping the Rules about this.
* Drug report barred by FDA/Scientist links
antidepressants to suicide in kids, Sunday, February 1, 2004 (SF
Chronicle), Rob Waters, Special to The Chronicle
* Talking back to Prozac: David Healy was
among the first psychiatrists to prescribe Prozac. Now he's one of the fiercest
critics of Big Pharma's "marketing" of depression. Did his outspoken views cost
him his job? By Joshua Kendall, The
Boston Globe, 2/1/2004
* Antidepressants & Suicide: Lawsuits
target drug makers, New Jersey Star-Ledger, Friday, January 30, 2004.
* Antidepressant Makers Withhold Data on
Children, washingtonpost.com, By Shankar Vedantam, Washington Post
Staff Writer, Thursday, January 29, 2004; Page A01
* Oh, behave! By Joe Studwell
Financial Times, Published: January 23 2004
* Allen Jones May 8, 2004, lawsuit against
the Pennsylvania Inspector General's office over retaliation for filing
a previous civil rights action and for speaking out about corruption in
Pennsylvania's psychiatric drug purchases.
* A Suicide Side Effect? What parents aren't
being told about their kids' antidepressants. San Francisco
Chronicle, January 4, 2004.
* The psychiatric protection order for the
“battered mental patient,” by Thomas Szasz. BMJ (British Medical
Journal) Vol. 327 20–27 December 2003, 1449-51.
* Over-medication: a growing crisis:
Aggressive marketing a major culprit, By Lou Dobbs. October 2,
2003.
* Does Medicaid Pay Too Much for Prescription
Drugs? A Case Study of Atypical Anti-Psychotics, by Mark Duggan,
University of Chicago and
NBER
* Is it Prozac or Placebo.
* Psychiatric Medications, Illicit Drugs,
& Alcohol, By Bruce Levine
* Frontline Investigates whether FDA Assuring
Drug Safety.
* Civil Commitment Due To Mental Illness And
Dangerousness: The Union Of Law And Psychiatry Within A Treatment-Control
System, by Bernadette Dallaire, Michael McCubbin, Paul Morin, and David
Cohen, Sociology of Health & Illness; Sep2000, Vol. 22
Issue 5, p679, 21p
* SSRI discontinuation syndrome in
Postgraduate Medicine
* "What if ADHD Really Doesn't Exist?"
by: Tony Zizza, AbleChild.org
* Critique of Medical-Coercive Psychiatry
by Ron Leifer M.D.
* Coercive psychiatry, human rights and
public participation by Richard Gosden
* The Effects of Medicating or Not Medicating
on the Treatment Process by Bertram P. Karon, Ph.D.
* Three Part Series: Problems With Forced
Psych Drug Treatment, by Nicholas Regush
* Part One
* Part Two
* Part Three
* Trauma Within ghe Psychiatric
Setting: A Preliminary Empirical Report, by Karen J. Cusack, B.
Christopher Frueh, Thom Hiers, Samantha Suffoletta-Maierle, and Sandy Bennett, Administration
and Policy in Mental Health, Vol. 30, No. 5, May 2003 (2003)
* The Other Drug War: Big Pharma’s 625
Washington Lobbyists from Public Citizen, July 2001.
* The Right to Refuse Treatment by
Grace E. Jackson, MD
* Therapeutic Jurisprudence: Embracing a
Tainted Ideal, by Arthur G. Christean
* ADHD: Total, 100% Fraud, by Fred A.
Baughman Jr., Neurologist, Pediatric Neurologist, Fellow,
American Academy of Neurology
* Insanity Pleas in the City Limits
Monthly, May 2000.
* The MacArthur Coercion Study Executive
Summary February 2001
* Mandated Community Treatment: Beyond
Outpatient Commitment, by John Monahan, Ph.D, Richard J. Bonnie, LL.B,
Paul S. Appelbaum, M.D., Pamela S. Hyde, J.D., Henry J. Steadman, Ph.D., and
Marvin S. Swartz, M.D.
* Do Psychiatric Inmates in New York Have the
Right to Refuse Drugs? An Examination of Rivers Hearings in the Brooklyn
Court
* Why Psychiatric Drugs Are Always Bad
by Douglas C. Smith, M.D
* The Bureaucratic Destruction of Patients'
Faith in Their Doctors: Public Psychiatry's Negative Lessons for General
Medicine, by Nathaniel S. Lehrman, Bulletin of the New York Academy of
Medicine, Winter 1994, Vol. 71, No. 2; 194-217.
* On Being Sane In Insane Places, by
David L. Rosenham, Science, Vol. 179 (Jan. 1973), 250-258. This is
the classic study where journalists posed as mentally ill and the psychiatrists
couldn't tell (but the patients could).
------------------------------------------------------------------------
FAIR USE NOTICE: These links may contain copyrighted (© ) material the use of
which has not always been specifically authorized by the copyright owner. Such
material is made available to advance understanding of ecological, political,
human rights, economic, democracy, scientific, moral, ethical, and social
justice issues, etc. It is believed that this constitutes a 'fair use' of any
such copyrighted material as provided for in section 107 of the US Copyright
Law. In accordance with Title 17 U.S.C. Section 107, this material is used for
non-profit educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml.
If you wish to use copyrighted material for purposes of your own that go beyond
'fair use', you must obtain permission from the copyright owner. Any
copyright owner who objects to the use of their copyrighted material should
send an e-mail to webmaster@psychrights.org.
------------------------------------------------------------------------
Last modified 11/6//2005
Copyright © 2003-2005 Law Project for Psychiatric Rights. All Rights Reserved
 Back
to top
|